Insights

Niche Market Focus Grifols Therapeutics operates within the specialized research services sector, providing tailored solutions that could benefit pharmaceutical and biotech companies seeking innovative research support, representing a targeted opportunity for specialized service offerings.

Moderate Revenue Scale With annual revenues estimated between 25 million and 50 million dollars, the company is positioned as a growing enterprise, potentially receptive to scalable solutions that can enhance its research capabilities and operational efficiency.

Research Triangle Presence Located in the Research Triangle Park area, a hub for biotech and pharmaceutical innovation, Grifols Therapeutics is well-positioned to collaborate with or expand services targeting the regional life sciences ecosystem.

Limited Workforce Employing between 11 and 50 staff members, the company may benefit from technology or services that streamline research processes, improve data management, or support talent development to boost productivity.

Growth Potential Opportunity Given its size and market niche, Grifols Therapeutics represents a viable client for advanced research tools, regulatory consulting, or collaborative partnerships aimed at expanding its research output and market presence.

Similar companies to Grifols Therapeutics, Inc.

Grifols Therapeutics, Inc. Tech Stack

Media & News

Grifols Therapeutics, Inc.'s Email Address Formats

Grifols Therapeutics, Inc. uses at least 1 format(s):
Grifols Therapeutics, Inc. Email FormatsExamplePercentage
First.Last@grifols.comJohn.Doe@grifols.com
82%
FirstL@grifols.comJohnD@grifols.com
4%
First.Middle@grifols.comJohn.Michael@grifols.com
3%
Last.F@grifols.comDoe.J@grifols.com
3%
First.L@grifols.comJohn.D@grifols.com
1%
FLast@grifols.comJDoe@grifols.com
1%
First.MiddleLast@grifols.comJohn.MichaelDoe@grifols.com
1%
F.Last@grifols.comJ.Doe@grifols.com
1%
First@grifols.comJohn@grifols.com
1%
FirstLast@grifols.comJohnDoe@grifols.com
1%
LastFi@grifols.comDoeJo@grifols.com
1%
FiLast@grifols.comJoDoe@grifols.com
1%

Frequently Asked Questions

Where is Grifols Therapeutics, Inc.'s headquarters located?

Minus sign iconPlus sign icon
Grifols Therapeutics, Inc.'s main headquarters is located at 79 tw Alexander Drive 4101 Research Commons Durham, North Carolina 27709 United States. The company has employees across 1 continents, including North America.

What is Grifols Therapeutics, Inc.'s NAICS code?

Minus sign iconPlus sign icon
Grifols Therapeutics, Inc.'s NAICS code is 5417 - Scientific Research and Development Services.

How many employees does Grifols Therapeutics, Inc. have currently?

Minus sign iconPlus sign icon
As of December 2025, Grifols Therapeutics, Inc. has approximately 39 employees across 1 continents, including North America. Key team members include Vice President And Site Head: D. B.Vice President - Research & Development: D. M.Sr Director & Head, R&d Program Management Office: J. W.. Explore Grifols Therapeutics, Inc.'s employee directory with LeadIQ.

What industry does Grifols Therapeutics, Inc. belong to?

Minus sign iconPlus sign icon
Grifols Therapeutics, Inc. operates in the Research Services industry.

What is Grifols Therapeutics, Inc.'s email format?

Minus sign iconPlus sign icon
Grifols Therapeutics, Inc.'s email format typically follows the pattern of First.Last@grifols.com. Find more Grifols Therapeutics, Inc. email formats with LeadIQ.

When was Grifols Therapeutics, Inc. founded?

Minus sign iconPlus sign icon
Grifols Therapeutics, Inc. was founded in 2004.

Grifols Therapeutics, Inc.

Research ServicesNorth Carolina, United States11-50 Employees

Grifols Therapeutics, Inc. is a research company based out of 79 TW ALEXANDER DR 4101 RESEARCH COMMONS, Research Triangle Park, North Carolina, United States.

Section iconCompany Overview

Headquarters
79 tw Alexander Drive 4101 Research Commons Durham, North Carolina 27709 United States
NAICS Code
5417 - Scientific Research and Development Services
Founded
2004
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $25M$50M

    Grifols Therapeutics, Inc.'s revenue is estimated to be in the range of $25M$50M

Section iconFunding & Financials

  • $25M$50M

    Grifols Therapeutics, Inc.'s revenue is estimated to be in the range of $25M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.